PPT-Cervical Screening in Practice

Case Studies Learning objectives Demonstrate current knowledge of the National Cervical Screening Program NCSP and how this applies to clients Case study 1 Jenny Jenny 24 yo attends your clinic for a routine appointment and you notice she is overdue for cervical screening She received her full HPV vaccination in high school . Screening Initiation Cervical cancer screening should begin at age 21 or approximately 3 years after 64257rst intimate sexual activity whichever occurs later Intimate sexual activity includes intercourse as well as digital or oral sexual activity in . KrisEmily. . McCrory. , MD. Objectives:. Review cervical cancer epidemiology and . pathophysiology. Identify the role of the Human . Papilloma. Virus in cervical cancer. Explain the use of HPV testing in cervical cancer screening. Based on 2012 Guidelines & Recommendations. Sarah Lamanuzzi, MD, FAAFP. Disclosures. I have no disclosures other than: the ASCCP gave permission for use of their slide content.. The American Society for Colposcopy and Cervical Pathology. “Cervical Cancer Screening Recommendations, . Based on the 2012 Recommendations (ASCCP). Sarah Lamanuzzi, MD, FAAFP. Disclosures. I have no disclosures other than: the ASCCP gave permission for use of their slide content.. The American Society for Colposcopy and Cervical Pathology. “Cervical Cancer Screening Recommendations, . Hazel Lewis. Public Health Physician. Wellington. Cartwright Forum, 7 August 2015. NCSP. -. R. centralised. 1965. 1990. 2000. 1988. Cartwright Report. NCSP . established . In 14 AHB. 1996. NSU. Gisborne Inquiry (CSI). Annual CPCRN Meeting, Chicago. Tuesday, May 24. th. . Lead: Karen Glanz, PhD, MPH. Participating Sites: . UPenn. , UNC, . UWash. , CDC, NCI. This presentation was supported by Cooperative Agreement Number U48 DP005053 from the Centers for Disease Control and Prevention. The findings and conclusions in this presentation are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention. . Prepared by : . Khalid . Aldossari. Fahad. . Alshehri. Ali Al-Mater. Supervised by : Dr. ELSHEIKH. Out lines :. WHO principles for screening tests .. HPV ( . infection , prevention , vaccination . CERVICAL CANCER. 4th most common cancer in women worldwide. CERVICAL CANCER. 4th most common cancer in women worldwide. >250,000 deaths/year. CERVICAL CANCER. 4th most common cancer in women worldwide. Cervical cancer. Cervical cancer is one of the . most preventable . cancers. Human papillomavirus (HPV). Over 99% of cervical cancer is caused by HPV. ‘Common cold of sexual activity’. Usually no symptoms. Cancer. (Resource-Stratified). SH-. Shiekhhasani. GYN.Oncologist. TEHRAN UNIVERSITY. Cervical cancer is the . fourth most common cancer . and . fourth leading cause of cancer-related mortality. in women worldwide.. Host. – . Mandeep Singh . Ahluwalia. Speakers. – Mandeep Ahluwalia, Karen Burgess, Bikram Raychaudhuri, Jane Lodge and Amy Dissanayake. . . . The webinar will commence at 1pm. Please remember to turn off your mics and cameras. Screening Programme. Dr G Dorman. QA Lead for Colposcopy. Cervical cancer. 80-90 new cases of invasive cervical cancer per year . 30-40 deaths per year. Associated with persistent infection with high risk subtypes of Human Papilloma Virus (HPV). . Kelly S, Mc Fadden SL. School of Life and Health Sciences, University of Ulster . Jordanstown. . Introduction. Aim. Methodology. The aetiological factors associated with cervical cancer are relatively unknown, however scientific evidence links persistent infection with human papilomavirus (HPV) and the development of cervical carcinomas. . (Preliminary Results). Hawa Camara. |. November 17. th. , 2018. Facts about Cervical cancer in PNG. 2. Experiences of PoC HPV-DNA cervical screening in PNG. Need for improved screening services. 3.